Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
about
Heart failure in patients with chronic kidney disease: a systematic integrative reviewIs controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST).Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formationHyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment.Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study.Cardiovascular effects of sevelamer in stage 3 CKD.Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal studyMineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study.Factors associating with oxygenation of lower-limb muscle tissue in hemodialysis patients.Stirring the Pot: Can Dietary Modification Alleviate the Burden of CKD?Can we reduce the cardiovascular risk in peritoneal dialysis patients?Heart failure and kidney dysfunction: epidemiology, mechanisms and management.The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study.Serum phosphate and outcome at one year after deceased donor renal transplantation.Risk factors for heart valve calcification in chronic kidney disease.Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway.Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation.
P2860
Q26824149-61931663-2777-47AC-8444-5D0523F6DB7AQ33880308-7FCE5860-6598-4319-9B07-61B0FB60D031Q35088034-F8DDBC84-CFD3-43C7-9BF8-ABF1AA9F4DF8Q35157648-EDB48E52-D23A-4D86-AF39-30D60D6DECBEQ35592504-686A73A4-EE35-4A86-87B7-B928E0C4F64BQ36042721-79A58107-6488-404B-AD69-1FB58676F60BQ36796599-CFAAA2D5-069D-4380-8A91-F806AF83A673Q36862354-249308CD-8363-4BFA-81EC-10DEBDBC0624Q37378445-96D219CA-C5B9-49E6-9AC2-4367FC08E075Q37399690-98AB85CF-3948-48D1-9340-DF90E48A29AAQ37729792-0E164E6D-F861-4FE7-A51E-2A4BDF1C5959Q37787773-BC1E05B4-E271-42D6-8166-F5686D01B5D7Q38826590-0B6C5C96-CDF3-4816-A226-5DDE36008044Q40200123-D7B4E185-7ECA-474C-A901-0C22981E1BDCQ45904499-1A92A49A-8AC8-484E-B7CA-7F82CCF50E27Q49557576-BBD7281B-E4EA-4CEF-A117-8CE91F4E2406Q52673652-AEE175C1-87AD-4899-9B87-F36C5A09D051Q55496554-BAC6B95C-B82B-440F-A23B-86DC6F63FBA1
P2860
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
@ast
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
@en
type
label
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
@ast
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
@en
prefLabel
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
@ast
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
@en
P356
P1476
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
@en
P2093
Juan Carlos Ayus
Steven G Achinger
P304
P356
10.1681/ASN.2006080923
P433
12 Suppl 3
P577
2006-12-01T00:00:00Z